Annual General Meeting 2017

The shareholders in Oncopeptides AB (publ), reg. no. 556596-6438 (“Oncopeptides” or the “Company”), are hereby given notice to attend the Annual General Meeting to be held in the Banquet room at IVA Conference center, Grev Turegatan 16, Stockholm, Sweden, Thursday 18 May 2017 at 4.00 p.m. Coffee will be served starting at 3.00 p.m., at which time the registration for attendees will commence.

Right to participate and notice

Shareholders who wish to participate at the Annual General Meeting must be entered in the share register of the Company, kept by Euroclear Sweden AB (the Swedish Central Securities Depository & Clearing Organisation), on 12 May 2017 and must notify their intention to participate to the Company so that the notification is received by the Company no later than 12 May 2017. Shareholders or proxies may bring one or two assistants at the Annual General Meeting if notification of the number of assistants the shareholder intends to bring has been made to the Company no later than the aforementioned time.

The notification shall be made either in writing to Oncopeptides AB (publ), Västra Trädgårdsgatan 15, 111 53 Stockholm, Sweden, or by e-mail to adrienne.martin-lof@oncopeptides.se.

The notification shall include name, personal identification number or corporate registration number, address and daytime telephone number and, where appropriate, name of assistants, proxy or representative. A notification form is available on the Company’s website www.oncopeptides.se.

Nominee registered shares

In order to be entitled to participate at the Annual General Meeting, shareholders who have their shares registered in the name of a nominee must temporarily re-register the shares in their own name. Shareholders who wish to make such re-registration, so-called voting rights registration, must make such request with their nominee well in advance of 12 May 2017, at which time the re-registration must have been made.

Proxy

Shareholders intending to participate by proxy must issue a written, signed and dated power of attorney for the proxy. If the power of attorney is issued by a legal entity, the power of attorney shall be accompanied by a certified copy of a valid registration certificate of the legal entity (or similar document for a non-Swedish legal entity). The documents must not be older than five years. Power of attorney forms are available on the Company’s website www.oncopeptides.se.

In order to facilitate registration, original versions of powers of attorney, certificates of registration and other authorization documents should be sent to the Company at the above address well in advance of the Annual General Meeting.